Research Directory

Highlights of the new EU Clinical Trials Regulation

Read more

Fighting bacterial infection with phage therapy

Read more

New agents fight B-cell malignancies

Read more

Collaboration to deliver superior value to patients

Read more

Why European biopharma is starved for capital

Read more

A greater patient voice in drug development

Read more

Biotechs are energised - at least for now

Read more

Getting traction against antimicrobial resistance

Read more

Expanding medicine access through formulation

Read more

Build-to-buy model attracts Pharma investors

Read more